Phagocytosis checkpoints as new targets for cancer immunotherapy

Written By Lara Wilson

Jiang W. et al. 2012. Nature Reviews Cancer. 19 (10), 568-586.

Lara Wilson
Previous

Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells
Next

Disrupting LILRB4/APOE interaction by an efficacious humanized antibody reverses T-cell suppression and blocks AML development